| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/BIT.25477 |
| P8608 | Fatcat ID | release_x2vg75uolramxiz3pa64onnham |
| P932 | PMC publication ID | 4689600 |
| P698 | PubMed publication ID | 25312394 |
| P50 | author | William M. Miller | Q41433424 |
| P2093 | author name string | Alaina C Schlinker | |
| Kyungyoon Min | |||
| Christopher Wegener | |||
| Katherine Radwanski | |||
| P2860 | cites work | Glycoprotein Ibα receptor instability is associated with loss of quality in platelets produced in culture | Q84305106 |
| The role of bicarbonate in platelet additive solution for apheresis platelet concentrates stored with low residual plasma | Q84439579 | ||
| Cell adhesive and antifouling polyvinyl chloride surfaces via wet chemical modification | Q84499246 | ||
| In vitro variables of apheresis platelets are stably maintained for 7 days with 5% residual plasma in a glucose and bicarbonate salt solution, PAS-5 | Q84595473 | ||
| Manipulation of oxygenation and flow-induced shear stress can increase the in vitro yield of platelets from cord blood | Q84857092 | ||
| Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes | Q86657049 | ||
| Nuclear matrix protein is released from apoptotic white cells during cold (1-6 degrees C) storage of concentrated red cell units and might induce antibody response in multiply transfused patients | Q30841203 | ||
| Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells | Q33392928 | ||
| Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets | Q33397149 | ||
| Caspase-9 mediates the apoptotic death of megakaryocytes and platelets, but is dispensable for their generation and function | Q33399439 | ||
| Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells | Q33413336 | ||
| Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice | Q33789872 | ||
| Anucleate platelets generate progeny | Q33834761 | ||
| Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional | Q34293080 | ||
| Cytoskeletal mechanics of proplatelet maturation and platelet release. | Q34317068 | ||
| Novel and unexpected clearance mechanisms for cold platelets | Q35000878 | ||
| Three-dimensional system for the in vitro study of megakaryocytes and functional platelet production using silk-based vascular tubes | Q35579676 | ||
| The tumourigenicity of iPS cells and their differentiated derivates | Q37295432 | ||
| Consensus and controversies in platelet transfusion | Q37589285 | ||
| Approaches to minimize infection risk in blood banking and transfusion practice | Q37837937 | ||
| Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations | Q38007560 | ||
| Commercially available blood storage containers. | Q38150422 | ||
| Residual undifferentiated cells during differentiation of induced pluripotent stem cells in vitro and in vivo | Q39532413 | ||
| Ex vivo large-scale generation of human platelets from cord blood CD34+ cells | Q40290226 | ||
| Generation of functional culture-derived platelets from CD34+ progenitor cells to study transgenes in the platelet environment | Q40490925 | ||
| Increased megakaryopoiesis in cultures of CD34-enriched cord blood cells maintained at 39 degrees C. | Q40521527 | ||
| Outside-In signaling of soluble and solid-phase fibrinogen through integrin alphaIIbbeta3 is different and cooperative with each other in a megakaryoblastic leukemia cell line, CMK. | Q41018862 | ||
| Phorbol ester enhances integrin alpha IIb beta 3-dependent adhesion of human erythroleukemic cells to activation-dependent monoclonal antibodies. | Q41235859 | ||
| Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production | Q41433371 | ||
| Prolonged continuous in vitro human platelet production using three-dimensional scaffolds | Q43136245 | ||
| Platelet formation is the consequence of caspase activation within megakaryocytes | Q44083637 | ||
| Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand | Q44476552 | ||
| Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease | Q46418067 | ||
| Efficient in vitro megakaryocyte maturation using cytokine cocktails optimized by statistical experimental design. | Q50955292 | ||
| The resistance to blood flow in the capillaries. | Q54655996 | ||
| Effects of a 2-step Culture with Cytokine Combinations on Megakaryocytopoiesis and Thrombopoiesis from Carbon-ion Beam-irradiated Human Hematopoietic Stem/progenitor Cells | Q57764377 | ||
| The origin of platelet count and volume | Q70642675 | ||
| In vitro platelet ageing at 22°C is reduced compared to in vivo ageing at 3 7°C | Q71785400 | ||
| Apoptotic markers are increased in platelets stored at 37 degrees C | Q73567612 | ||
| Production of functional platelets by differentiated embryonic stem (ES) cells in vitro | Q73812286 | ||
| Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors | Q81015137 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 788-800 | |
| P577 | publication date | 2014-11-19 | |
| P1433 | published in | Biotechnology and Bioengineering | Q4915339 |
| P1476 | title | Separation of in-vitro-derived megakaryocytes and platelets using spinning-membrane filtration | |
| P478 | volume | 112 |
| Q92546005 | A comparison of haematopoietic stem cells from umbilical cord blood and peripheral blood for platelet production in a microfluidic device |
| Q47257067 | A uniform-shear rate microfluidic bioreactor for real-time study of proplatelet formation and rapidly-released platelets |
| Q97533489 | In vitro platelet production for transfusion purposes: Where are we now? |
| Q90733820 | Induction of differentiation of human stem cells ex vivo: Toward large-scale platelet production |
| Q33424186 | Manipulating megakaryocytes to manufacture platelets ex vivo |
| Q38777454 | Megakaryocyte Polyploidization and Proplatelet Formation in Low-Attachment Conditions |
| Q33438649 | Platelet bioreactor: accelerated evolution of design and manufacture |
| Q40115861 | Platelet production from induced pluripotent stem cells |
| Q35252648 | Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies. |
| Q38784723 | Recent developments in ex vivo platelet production. |
| Q33442786 | Towards the Manufacture of Megakaryocytes and Platelets for Clinical Application. |
| Q60921626 | Traditional and emerging technologies for washing and volume reducing blood products |
| Q26770860 | Understanding platelet generation from megakaryocytes: implications for in vitro-derived platelets |
Search more.